logo

Taysha Gene Therapies Inc (TSHA) Stock: Navigating Market Highs and Lows in 52 Weeks

Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Taysha Gene Therapies Inc’s current trading price is -60.01% away from its 52-week high, while its distance from the 52-week low is 45.17%. The stock’s price range during this period has varied between $1.19 and $4.32. The company, active in the Healthcare sector, saw a trading volume of around 1.63 million for the day, considerably lower average daily volume of 4.14 million observed over the last three months.

Taysha Gene Therapies Inc’s stock has had a calm market performance. The 1-year high for the company’s stock was $4.32 on 06/13/24, and the lowest price during the same period was recorded at $1.19 on 11/05/24.

How Financial Performance Impacts Market Capitalization

Taysha Gene Therapies Inc (TSHA) has experienced a quarterly rise of 36.02% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 354.04M and boasts a workforce of 52 employees.

The Role of Moving Averages and Trading Volume in Technical Analysis

Based on Barchart.com data, the company’s moving average over the 100-day period was 1.9712, with a change in price of -0.5350. Similarly, Taysha Gene Therapies Inc recorded 3,530,889 in trading volume during the last 100 days, posting a change of -23.36%.

How TSHA’s Debt-to-Equity Ratio Affects Financial Health

A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for TSHA stands at 0.70. Similarly, the long-term debt-to-equity ratio is also 0.68.

TSHA Stock Stochastic Average

As of today, the raw stochastic average of Taysha Gene Therapies Inc over the past 50 days is 17.07%. This is a decrease compared to the raw stochastic average of the last 20 days, which was recorded at 73.56%. Additionally, the Stochastic %K and %D values for the company were 53.06% and 38.05%, respectively, over the past 20 days.

TSHA Stock Price Performance Analysis

The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. Year to date metric has recorded a loss of -0.14%.However, over the last six months, we can see a stronger performance of -14.90%. Over the last 30 days, the price of TSHA has leaped by -8.11%. And in the last five days, it has surged by 15.17%.

Most Popular